News releases from the National Institutes of Health (NIH)
Updated: 17 hours 55 min ago
NIH-supported findings illustrate manifold benefit of therapy.
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Scientists find mice carrying gene variant consume excessive amounts of alcohol, despite negative consequences.
Biomarkers Consortium project to improve tools for measuring and treating social impairment in children with autism.
Lymphomas are caused by an abnormal proliferation of white blood cells and can occur at any age.
Science-based technology provides users greater customizing to help reach and sustain a healthy weight.
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
The National Institute of Nursing Research releases the publication as part of their Palliative Care: Conversations Matter campaign.
Campaign asks seniors to “Be Active Every Day!”.
Annual statistics compilation also shows increase in adolescent depression.
Risk of heat-related health problems increases with age.
A clinical trial of a new investigational vaccine designed to protect against West Nile Virus infection will be sponsored by the National Institute of Allergy and Infectious Diseases (NIAID).
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
NIH-funded study is the first look at antipsychotic prescriptions patterns in the U.S.
For preemies delivered by C-section, technique increases blood pressure, finds NIH-funded study.
Study will assess the safety and efficacy of gabapentin enacarbil for treating moderate to severe AUD.
Plan outlines aggressive timeline to achieve key milestones.
New members will serve terms through October 2017.
NIH team and colleagues believe microdevice may improve upon existing placenta models.
Trial to examine long-term health effects of Ebola virus disease.